This websites contains videos from YouTube. This company uses
cookies (third party cookies). If you do not want them to use these
cookies, you can indicate so here. However, this does mean that you
will not be able to watch videos on this website. We also make use
of our own cookies in order to improve our website. We don't share
our data with other parties. Which cookies are involved?
user experience. If you do not want to accept these cookies,
indicate so here. Which cookies are involved?
While some immunotherapies already help cancer patients,
many more of this type of drugs that are aimed at encouraging the
immune system to fight cancer are being developed. During her PhD
research Willeke Ros studied the efficacy and safety of several of
those medicines in the first patients. She also investigated
whether the already registered immunotherapy pembrolizumab could be
effective against rare tumors.
Research into the quality of life in cancer patients in the palliative care phase: Lonneke van de Poll on the eQuiPe study
Strange as this may sound, very little is known about the
quality of life of terminal cancer patients in the palliative care
phase. Medical practitioners are often uncertain of what they can
still offer such patients, their relatives and carers. The eQuiPe
study is going to change this state of affairs.